Miyazawa, Atsuhiro
Kanahara, Nobuhisa http://orcid.org/0000-0001-8550-8003
Kogure, Masanobu
Otsuka, Ikuo
Okazaki, Satoshi
Watanabe, Yoshinori
Yamasaki, Fumiaki
Nakata, Yusuke
Oda, Yasunori
Hishimoto, Akitoyo
Iyo, Masaomi
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K07476)
Article History
Received: 11 October 2021
Accepted: 24 November 2021
First Online: 29 November 2021
Declarations
:
: N.K. reports honoraria from Otsuka Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Janssen Pharmaceutical K.K., Meiji Seika Pharma Co., Ltd., and Mochida Pharmaceutical Co., Ltd. Y.M. received speaker’s honoraria from Pfizer Japan Inc., Otsuka Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Meiji Seika Pharma Co., Ltd., Eli Lilly Japan K.K., MSD K.K., a subsidiary of Merk and Co., Inc., Takeda Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., and Sumitomo Dainippon Pharma Co., Ltd. Y.N. reports honoraria from Sumitomo Dainippon Pharma Co., Ltd., and Meiji Seika Pharma Co., Ltd. Y.O. reports honoraria from Otsuka Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Meiji Seika Pharma Co., Ltd. M.I. received consultant fees from Eli Lilly Japan K.K., Sumitomo Dainippon Pharma Co., Ltd., Pfizer Japan Inc., Abbott Japan Co., Ltd. and Janssen Pharmaceutical K.K., and reports honoraria from Janssen Pharmaceutical K.K., Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Astellas Pharma Inc., Sumitomo Dainippon Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Takeda Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., MSD K.K., Eisai Co. Ltd., Daiichi-Sankyo Co. Ltd., Novartis Pharma K.K., Teijin Ltd., Shionogi and Co., Ltd., Hisamitsu Pharmaceutical Co., Inc. and Asahi Kasei Corporation. A.M., M.K., I.O., S.O., F.Y. and A.H. have no conflict of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study was conducted after approval by the ethics committee at Chiba University Graduate School of Medicine and Kobe University Graduate School of Medicine.
: All subjects provided their informed consent after receiving a full and detailed explanation of the study.
: All of the authors agreed on the submission to and publication from <i>Journal of Molecular Neuroscience</i>.